Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Coronary Prevention”

198 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 198 results

Not applicableStudy completedNCT00536965
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 951
Post-approval studies (Phase 4)Study completedNCT00272337
What this trial is testing

Aspirin Dose and Atherosclerosis in Patients With Heart Disease

Who this might be right for
Cardiovascular DiseasesAtherosclerosisMyocardial Infarction
Florida Atlantic University 37
Not applicableStudy completedNCT03760796
What this trial is testing

Myocardial Infarction, COmbined-device, Recovery Enhancement Study

Who this might be right for
Acute Myocardial InfarctionCoronary Artery DiseaseAcute Coronary Syndrome+1 more
Johns Hopkins University 200
Large-scale testing (Phase 3)Study completedNCT00283335
What this trial is testing

The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol

Who this might be right for
Coronary Heart Disease
VA Office of Research and Development 2,531
Post-approval studies (Phase 4)Study completedNCT02053909
What this trial is testing

Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis

Who this might be right for
Saphenous Vein Graft Disease
Boca Raton Regional Hospital 250
Not applicableLooking for participantsNCT03711110
What this trial is testing

Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)

Who this might be right for
Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)ElderlyAntineoplastic Agents+1 more
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León 514
Not applicableLooking for participantsNCT05817305
What this trial is testing

Integrating Exercise Into Lifestyle of Cardiac Outpatients

Who this might be right for
Cardiovascular DiseasesPhysical InactivityAging+2 more
Università degli Studi di Ferrara 5,000
Not applicableUnknownNCT03327350
What this trial is testing

WATCHMAN for Second Prevention of Stroke (WASPS)

Who this might be right for
Atrial FibrillationStroke
Second Affiliated Hospital, School of Medicine, Zhejiang University 400
Not applicableLooking for participantsNCT05835791
What this trial is testing

END - VT Cohort Study

Who this might be right for
Ventricular TachycardiaImplantable Defibrillator UserICD
Nova Scotia Health Authority 2,454
Not applicableStudy completedNCT00421876
What this trial is testing

GlObal Secondary Prevention strategiEs to Limit Event Recurrence After Myocardial Infarction. GOSPEL Study

Who this might be right for
Myocardial Infarction
Heart Care Foundation 3,200
Not applicableStudy completedNCT01621087
What this trial is testing

Dietary Linoleic Acid for Secondary Prevention of Coronary Heart Disease and Death in the Sydney Heart Study: an RCT

Who this might be right for
Coronary Heart Disease
National Institutes of Health Clinical Center (CC) 458
Not applicableStudy completedNCT00536796
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 1,096
Not applicableStudy completedNCT01871194
What this trial is testing

An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).

Who this might be right for
Atrial FibrillationDeep Vein ThrombosisPulmonary Embolism
Professor Saad Shakir 3,400
Not applicableEnrolling By InvitationNCT04617639
What this trial is testing

The Norwegian Trial of Physical Exercise After Myocardial Infarction

Who this might be right for
Myocardial Infarction
Norwegian University of Science and Technology 9,700
Not applicableLooking for participantsNCT06298864
What this trial is testing

Internet-based Behavioral Intervention Following ACS

Who this might be right for
Acute Coronary SyndromeOnline CBT Targeting Cardiac Anxiety
Karolinska Institutet 176
Not applicableActive Not RecruitingNCT07194811
What this trial is testing

Stroke of Unknown Cause in Women: The Impact of Long-term Heart Monitoring on Stroke Recurrence

Who this might be right for
Cryptogenic StrokeAtrial FibrillationImplantable Cardiac Monitor+4 more
University Hospital, Akershus 1,400
Not applicableStudy completedNCT02619422
What this trial is testing

More Intensive Cardiac Rehabilitation Programs in Less Time

Who this might be right for
Acute Coronary Syndrome
Almudena Castro Conde 509
Not applicableStudy completedNCT00660764
What this trial is testing

Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)

Who this might be right for
HypercholesterolemiaCoronary Heart DiseasePeripheral Vascular Disease+2 more
AstraZeneca
Not applicableLooking for participantsNCT06637657
What this trial is testing

Guided Optimisation of Long-term Disease rEduction in secoNdary Prevention of CVD

Who this might be right for
Acute Coronary Syndrome
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 5,586
Not applicableNot Yet RecruitingNCT07625228
What this trial is testing

Improving Management and Secondary Prevention Through Azithromycin Comparative Trial in Rheumatic Heart Disease in Nigeria)- IMPACT-RHD Nigeria

Who this might be right for
Rheumatic FeverValvular Heart DiseasesValvular Cardiomyopathy
Ladoke Akintola University of Technology, Ogbomoso, Nigeria 474
Load More Results